Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV
Depression is a known risk factor for antiretroviral therapy (ART) non-adherence, but little is known about the mechanisms explaining this relationship. Identifying these mechanisms among people living with HIV (PLHIV) after release from prison is particularly important, as individuals during this critical period are at high risk for both depression and poor ART adherence. 347 PLHIV recently released from prison in North Carolina and Texas were included in analyses to assess mediation of the relationship between depressive symptoms at 2 weeks post-release and ART adherence (assessed by unannounced telephone pill counts) at weeks 9–21 post-release by the hypothesized explanatory mechanisms of alcohol use, drug use, adherence self-efficacy, and adherence motivation (measured at weeks 6 and 14 post-release). Indirect effects were estimated using structural equation models with maximum likelihood estimation and bootstrapped confidence intervals. On average, participants achieved 79% ART adherence. The indirect effect of depression on adherence through drug use was statistically significant; greater symptoms of depression were associated with greater drug use, which was in turn associated with lower adherence. Lower adherence self-efficacy was associated with depressive symptoms, but not with adherence. Depression screening and targeted mental health and substance use services for depressed individuals at risk of substance use constitute important steps to promote adherence to ART after prison release.
KeywordsAntiretroviral therapy Adherence Depression Drug use Incarceration Mediation
This research was supported by the National Institute on Drug Abuse (R01 DA030793) and the UNC Center for AIDS Research (P30 AI50410). This research was partially supported by a National Research Service Award Post-Doctoral Traineeship from the Agency for Healthcare Research and Quality sponsored by The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill (T32 HS000032). Dr. Golin’s salary was partially supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K24 HD069204). Dr. Wohl’s salary (K24 DA037101) and Dr. Gottfredson’s salary (K01 DA035153) were partially supported by the National Institute on Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflicts of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 2.Centers for Disease Control and Prevention. HIV screening of male inmates during prison intake medical evaluation—Washington, 2006–2010. MMWR Morb Mortal Wkly Rep. 2011;60(24):811.Google Scholar
- 12.Ironson G, O’Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67:1013–21.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Babowitch J, Vanable PA, Sweeney SM. Self-efficacy mediates the association of depression to antiretroviral medication adherence among HIV-positive outpatients. Ann Behav Med. 2017;51:S2057.Google Scholar
- 28.Golin CE, Knight K, Carda-Auten J, Gould M, Groves J, White BL, et al. Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care. BMC Public Health. 2016;16:935.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Haley DF, Golin CE, Farel CE, Wohl DA, Scheyett AM, Garrett JJ, et al. Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners’ perspectives before and after community reentry. BMC Public Health. 2014;14:1253.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Kalichman SC, Amaral CM, Cherry C, Flanagan J, Pope H, Eaton L, Kalichman MO, Cain D, Detorio M, Caliendo A, Schinazi RF. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9(5):298–308.CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Simpson DD, Knight K, Broome KM. TCU/CJ forms manual: drug dependence screen and initial assessment. Fort Worth: Texas Christian University; 1997.Google Scholar
- 40.Chariyeva Z, Golin CE, Earp JA, Maman S, Suchindran C, Zimmer C. The role of self-efficacy and motivation to explain the effect of motivational interviewing time on changes in risky sexual behavior among people living with HIV: a mediation analysis. AIDS Behav. 2013;17:813–23.CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Muthén B. Applications of causally defined direct and indirect effects in mediation analysis using SEM in Mplus. 2011.Google Scholar
- 46.Tolliver BK, Anton RF. Assessment and treatment of mood disorders in the context of substance abuse. Dialog Clin Neurosci. 2015;17(2):181.Google Scholar